Welcome to ImmuVia

ENGINEERING THE FUTURE

ImmuVia develops novel antibody-based targeted therapeutics to treat oncological diseases. Founded in 2017, ImmuVia works on developing cutting-edge therapeutic products that make a difference in patients’ lives.

CORPORATE HISTORY

Timeline

2017

Founded by Iosif M. Gershteyn & Victor S. Goldmacher.

2019

First IP filings.

2020

Private Seed Round Executed.

2021

Seed Round Extension Secured.

2022

Corporate reorganization.

SOLID TUMORS

ImmuVia focuses on targeting solid tumors with high unmet medical need. ImmuVia is developing innovative biologics that selectively and precisely eradicate tumors. Unlike existing methods, our agents do not contain toxic substances and are not anticipated to cause cytokine release storms. 

Iosif M. Gershteyn

Chief Executive Officer

Serial entrepreneur in the biotech and medical device space.

Background in Finance and Corporate Strategy

Licensed project-generated IP for Medical Device development.

 

BA Brandeis
MAief Brandeis International Business School
Executive MBA – Quantic

Iosif M. Gershteyn,

Founder, CEO of ImmuVia

Victor S. Goldmacher

Chief Scientific Officer

Summary Paragraph pulvinar proin sit neque pellentesque elementum purus faucibus nunc tincidunt lorem sed posuere  congue faucibus rhoncus a ultrices nec at pulvinar convallis ac vitae amet .

PhD Moscow State University
Postdoctoral Associate MIT
Assistant Professor Harvard Medical School (DFCI)

Victor S. Goldmacher,

Founder, CSO of ImmuVia

OUR SCIENCE

Leveraging decades of experience, our team has identified high-value targets and developed biologic agents for effective eradiation of malignant cells.

TARGETING

Targets exclusively present on cancer cells, and not on normal cells

ANTIBODIES

Recombinant antibody-based proteins developed to induce death of targeted cells

BREAKTHROUGH

Innovative mode of tumor eradication compatible with standard manufacturing processes

NOT TOXIC

No recruitment of immune cells that could cause dangerous side effects

OUR TEAM

World-class experts coming together to create a comprehensive research and development team

Y??

VP of Biology

R????

VP of Biochemistry

G???

Senior Advisor on Manufacturing

Address

Boston, MA

Call Us

+1 123 456 7890

Email Us

info@immuvia.com